Skip to main content
OpenTrials
Completed

NCT Number: NCT01604538

Italian Pulmonary Embolism Registry - IPER

RAZIONALE

Pulmonary embolism is a complex disease, with a highly variable clincal presentation. Diagnosis starts with clinical probability assessment mainly based on medical history and rapidly available clinical data. Pulmonary embolism can be managed by emergency department, cardiology, pneumology geriatrics or internal medicine physicians. Thus, initial clinical management can varies based on the attitude of the attending physician.

Diagnosis is a crucial point as it can influence short term mortality.

OBJECTIVE

The registry has 3 main objectives:

1. educational objective, 2. improvement in the knowledge of epidemiology, management and outcome of acute pulmonary embolism in Italy 3. scientific objective

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • consecutive patients with acute pulmonary embolism

Exclusion criteria

  • age <18 years

Sponsors and collaborators

Lead sponsor

University Of Perugia

Other

Registry information

Official study title

Italian Pulmonary Embolism Registry

Acronym: IPER

Important dates

Study start
2006
First posted
May 23, 2012
Registry last updated
May 23, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.